Clinical Trials
64 trialsStem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers
National Institutes of Health Clinical Center (CC)
ROBDOG
Koç University
E-STOP2
Hospital Universitari Vall d'Hebron Research Institute
HematoCare
Azienda USL Reggio Emilia - IRCCS
Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia
Instituto de Investigación Biomédica de Salamanca
COMPLHEMATO
University Hospital, Limoges
Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe Myelofibrosis
Nanfang Hospital, Southern Medical University
A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological Malignancies
Kousai Bio Co., Ltd.
TITLE CLL
The Royal Wolverhampton Hospitals NHS Trust
Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT
University of Arizona
Safety and Efficacy of DIT101 in Relapsed or Refractory Hematologic Malignancies
Tcelltech Inc.
The Efficacy and Safety of Stereotactic Radiotherapy Bridging Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignance Patients With Extramedullary Infiltrating
Institute of Hematology & Blood Diseases Hospital, China
Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies
M.D. Anderson Cancer Center
CALySSEY
Baylor College of Medicine
The Safety and Efficacy of the Regimen of Thiotepa + Fludarabine +Granulocyte Colony-Stimulating Factor+ Cytarabine + Busulfan in Single Unrelated Umbilical Cord Blood Transplantation
Institute of Hematology & Blood Diseases Hospital, China
DETERMINE
Cancer Research UK
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
Ascentage Pharma Group Inc.
Assessing DCog Short for Neurotoxicity in CAR-T
Beth Israel Deaconess Medical Center
CARE-RT
Jinnah Postgraduate Medical Centre
Exploratory Study on in Vivo CAR-T Therapy Targeting CD20 for the Treatment of Hematological Malignancies
The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army
Exploratory Study on the Treatment of Recurrent and Refractory Hematological Malignancies With WGb-0302 Injection
Sichuan University
Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation
Massachusetts General Hospital
Adoption of Audio Recording in the Outpatient Supportive Care Center
M.D. Anderson Cancer Center
A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies
Affiliated Hospital of Jiangsu University
A Phase I Trial of QLS2313 Injection in Relapsed/Refractory Hematological Malignancies
Qilu Pharmaceutical Co., Ltd.
CASEY
Baylor College of Medicine
PEPOH
University of Salamanca
PREHAB-HSCT
Hospital del Salvador
NEO-COAG
University Hospital, Strasbourg, France
HAPLO2022
Miltenyi Biomedicine GmbH
A Study of BL-M24D1 in Patients With Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies
Sichuan Baili Pharmaceutical Co., Ltd.
MAHATMAt
Assistance Publique Hopitaux De Marseille
A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies
Biotroy Therapeutics
The Effect of a Protective Oral Care Protocol Using Peppermint Oil Mouthwash
Ankara University
Virtual Reality Intervention for Symptom Management in Stem Cell Transplantation
Halic University
A Clinical Study to Evaluate the Safety and Efficacy of Anti-human CD 7 CAR-NK Cell Injection in Subjects With Relapsed and Refractory CD7-positive Hematological Malignancy
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
ABO and Rh Blood Group Frequencies in Acute Leukemia Patients
Assiut University
TARGETALLO
Centre Hospitalier Universitaire de Nice
Prospective Study Evaluate the Timing of Empirical Treatment for Carbapenem-resistant Bacterials (CROEAT Study)
Shanghai Jiao Tong University School of Medicine
The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy
Peking University First Hospital
UNIVERSAL GENETIC TESTING OF PATIENTS WITH HEMATOLOGICAL MALIGNANCIES (UGT)
Augusta University
Early Clinical Study of JY306 Universal NK Cell Injection in the Treatment of Adult Relapsed or Refractory CD70+ Malignant Hematologic Tumors
The First Affiliated Hospital with Nanjing Medical University
Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of Patients with Hematological Cancer
Ciusss de L'Est de l'Île de Montréal
Antibiotic Stewardship in Suspected Neutropenic Fever (ASTERIC Trial)
The University of Hong Kong
A Study of the Effect of Laughter Therapy on the Mental Health and Quality of Survival of Hematopoietic Stem Cell Transplant Patients
Institute of Hematology & Blood Diseases Hospital, China
Using a Population Pharmacokinetic Model to Estimate the Dosage of Teicoplanin in Patients With Hematologic Malignancy or Critical Illness
National Taiwan University Hospital
VORIPRECI
University Hospital, Grenoble
Hemascopio
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Safety, Tolerability and Preliminary Efficacy of Erythrocyte-αPD-1 Conjugate in Patients With Advanced Malignancies
Zhejiang Provincial People's Hospital
HEMATOneeds
University of Modena and Reggio Emilia